Quit and Screen Project

Summary

The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.

The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Conditions

• Knowledge
• Attitudes
• Behavioral Intention

Interventions

OTHER

Quit and Screen Project training

This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.

OTHER

G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.

Sponsors & Collaborators

• Virginia Commonwealth University

  collaborator OTHER

• Coalition for a Tobacco Free Arkansas

  collaborator UNKNOWN

• National Institute on Minority Health and Health Disparities (NIMHD)

  collaborator NIH

• National Medical Association

  collaborator UNKNOWN

• University of Arkansas

  lead OTHER

Principal Investigators

• Pebbles Fagan, PhD, MPH · University of Arkansas

• Mignonne Guy, PhD · Virginia Commonwealth University

• Ashley Clawson, PhD · University of Arkansas

Study Design

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

21 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2026-09-01

Primary Completion

2027-04-30

Completion

2027-04-30

Countries

• United States

Study Locations